Indefinite Delivery Contract M0068111D0010

This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Specgx LLC (doing business as Mallinckrodt Pharmaceuticals) a $107.6 million ceiling to deliver a variety of pharmaceutical products to federal agencies. Key items include methadone, buprenorphine, and other controlled substances used for pain management, substance abuse treatment, and medical research. Through this IDV, the VA and other agencies like the Department of Defense, Bureau of...

This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Collegium Pharmaceutical Inc. The contract is for the provision of pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract has a ceiling value of $1,900,000.00 and a period of performance through November 30, 2025. As an FSS contract, this is a multiple-award vehicle that allows other federal agencies to place orders against the contract. The...

This Federal Supply Schedule (FSS) contract awarded to Indivior Inc. provides the Department of Veterans Affairs (VA) with a $131.9 million ceiling value Indefinite Delivery Vehicle (IDV) to procure various drugs, pharmaceuticals, and hematology-related products through June 2025. As the prime contractor, Indivior Inc. is a for-profit pharmaceutical manufacturer that specializes in developing treatments for opioid use disorder and overdose. Under this multiple-award FSS contract, Indivior has...

The Federal Supply Schedule contract awarded to Purdue Pharma LP by the Department of Veterans Affairs' Health Administration network provides a $243,488,600.00 multiple award indefinite delivery vehicle for pharmaceuticals and drugs under GSA Schedule 65 IB. The 5-year contract, which runs from May 2022 to April 2027, allows the VA's Veterans Integrated Service Network 12 to place task orders for a variety of prescription and over-the-counter medications commonly used in hospital and clinical...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Clarus Therapeutics, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. With a potential value of $225,000 and a period of performance through May 2025, this multiple-award IDV aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network. The original solicitation sought offers under...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Scilex Pharmaceuticals Inc., a for-profit organization, on March 1, 2019. The contract has a ceiling value of $300,000.00 and an ultimate completion date of January 31, 2026. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract...

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, provides for the delivery of pharmaceuticals, drugs, and hematology-related products. The $24,000,000 multiple-award contract has a period of performance through August 31, 2026. The prime contractor is Biodelivery Sciences International, Inc., a for-profit manufacturer of goods. Biodelivery Sciences' parent company is Collegium Pharmaceutical Inc....

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 has awarded a Federal Supply Schedule (FSS) contract to Zogenix, Inc. for Drugs, Pharmaceuticals, & Hematology Related Products (FSS-61-IB). This multiple award contract has a potential value of $250,000.00 and a period of performance from April 1, 2021 to March 31, 2026. The contract aims to procure a variety of pharmaceutical and drug products that fall under the Pharmaceuticals and...

The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...